MedTrace Logo

Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis

NCT06943807 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2026-02-25

No results posted yet for this study

Summary

This is a prospective study designed to evaluate the efficacy of a multi-target fecal DNA test for the early detection of gastric cancer. The test combines Helicobacter pylori gene detection with analysis of fecal methylated DNA markers. The primary objective is to assess whether each method, individually or in combination, can facilitate earlier diagnosis of gastric cancer. All participants will undergo the multi-target fecal DNA test and complete the gastric cancer risk questionnaire.

Conditions

  • Gastric (Stomach) Cancer

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2026-08-30
Completion
2027-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06943807 on ClinicalTrials.gov